IRIS
ANGARANO, Gioacchino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.197
AS - Asia 9.553
EU - Europa 8.794
SA - Sud America 2.796
Continente sconosciuto - Info sul continente non disponibili 666
AF - Africa 433
OC - Oceania 13
AN - Antartide 2
Totale 48.454
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.864
SG - Singapore 3.888
IT - Italia 2.677
BR - Brasile 2.229
CN - Cina 2.138
DE - Germania 1.520
HK - Hong Kong 1.507
SE - Svezia 869
UA - Ucraina 834
RU - Federazione Russa 749
FI - Finlandia 652
VN - Vietnam 561
FR - Francia 554
GB - Regno Unito 466
IN - India 318
BD - Bangladesh 255
AR - Argentina 191
CA - Canada 151
IQ - Iraq 124
CI - Costa d'Avorio 119
ID - Indonesia 109
ZA - Sudafrica 96
EC - Ecuador 95
MX - Messico 91
CO - Colombia 82
TR - Turchia 81
PK - Pakistan 74
VE - Venezuela 71
SA - Arabia Saudita 68
BE - Belgio 65
IE - Irlanda 59
JP - Giappone 58
PL - Polonia 55
MA - Marocco 51
ES - Italia 48
UZ - Uzbekistan 47
NL - Olanda 45
PY - Paraguay 43
PH - Filippine 39
KE - Kenya 36
TN - Tunisia 36
CL - Cile 34
JO - Giordania 32
AT - Austria 31
MK - Macedonia 29
IR - Iran 26
MY - Malesia 25
EG - Egitto 22
AE - Emirati Arabi Uniti 21
IL - Israele 20
NP - Nepal 19
AZ - Azerbaigian 18
ET - Etiopia 17
UY - Uruguay 17
PE - Perù 16
KZ - Kazakistan 15
LB - Libano 15
BO - Bolivia 14
CR - Costa Rica 14
JM - Giamaica 14
LT - Lituania 14
BG - Bulgaria 13
OM - Oman 13
PS - Palestinian Territory 13
RO - Romania 13
RS - Serbia 13
TH - Thailandia 13
HN - Honduras 12
HR - Croazia 12
AU - Australia 11
CZ - Repubblica Ceca 11
GE - Georgia 11
GR - Grecia 11
DZ - Algeria 10
EU - Europa 10
NI - Nicaragua 10
AL - Albania 9
BY - Bielorussia 9
KW - Kuwait 9
NG - Nigeria 9
CH - Svizzera 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
HU - Ungheria 6
LY - Libia 6
PT - Portogallo 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AO - Angola 5
PA - Panama 5
QA - Qatar 5
XK - ???statistics.table.value.countryCode.XK??? 5
BB - Barbados 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
AM - Armenia 3
BW - Botswana 3
GT - Guatemala 3
KH - Cambogia 3
KR - Corea 3
Totale 47.739
Salva come PNG Salva come JPEG
Città #
Fairfield 2.712
Ashburn 2.079
Singapore 1.994
Woodbridge 1.991
Jacksonville 1.864
Chandler 1.701
San Jose 1.504
Houston 1.499
Hong Kong 1.488
Seattle 1.119
Milan 1.071
Wilmington 1.006
Cambridge 908
Ann Arbor 837
Council Bluffs 629
Nyköping 575
Dallas 503
Beijing 493
Lawrence 464
Roxbury 463
Nanjing 448
Lauterbourg 411
New York 378
Rome 368
Boardman 295
Des Moines 293
Los Angeles 283
Princeton 231
Helsinki 200
Santa Clara 186
São Paulo 186
Ho Chi Minh City 175
Columbus 156
Bari 137
Buffalo 131
Shenyang 128
Hebei 120
Abidjan 119
Hanoi 119
Inglewood 118
San Diego 116
Munich 113
Dearborn 111
Nanchang 110
Brooklyn 104
Figino 96
London 75
Chicago 73
Jiaxing 73
Rio de Janeiro 73
Turin 73
Tianjin 69
Dublin 58
Tokyo 55
Baghdad 53
Falkenstein 52
Brussels 49
Naples 49
Belo Horizonte 46
Dong Ket 46
Jakarta 46
Moscow 46
Curitiba 45
Guangzhou 45
Pune 45
Brasília 43
Warsaw 43
Frankfurt am Main 42
Changsha 38
Phoenix 38
San Francisco 38
Tashkent 38
Atlanta 37
Johannesburg 37
Orem 37
Paris 35
Montreal 34
Toronto 34
Denver 31
Guayaquil 31
Mexico City 31
Taranto 31
Chennai 30
Nairobi 30
New Delhi 30
Campinas 29
Hefei 29
Salvador 29
Porto Alegre 28
Amman 27
Dhaka 27
Quito 27
Stockholm 27
Nuremberg 26
Asunción 25
Caracas 25
Da Nang 25
Mumbai 25
Riyadh 25
Washington 25
Totale 32.210
Salva come PNG Salva come JPEG
Nome #
Anemia as a risk factor for disease progression in patients admitted for COVID-19: data from a large, multicenter cohort study 424
Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV coinfected individuals 389
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 370
Sphingomonas paucimobilis outbreak in a dialysis room: Case report and literature review of an emerging healthcare associated infection 281
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 248
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 226
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 223
Access to health services for undocumented immigrants in Apulia. 217
Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates 214
Cerebrospinal fluid compartmentalization of HIV-1 and correlation with plasma viral load and blood–brain barrier damage 208
HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ? 202
HIV-RNA decay in paired blood and semen samples of subjects receiving their first dolutegravir-based ART regimen 200
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 194
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. 189
An outbreak of HIV-1 BC recombinants in Southern Italy 187
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 182
Access to HAART in HIV-Infected Immigrants: A Retrospective Multicenter Italian Study 179
An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia 179
Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients 176
HIV-1 coreceptor tropism: A syllogistic connection with the veterans aging cohort study index and the CD4/CD8 ratio 173
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin. 172
" INFEZIONI DA CLAMYDIA PNEUMONIAE IN PAZIENTI CON A.I.D.S. " 171
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 170
Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 170
Cryptosporidiosis in the acquired immunodeficiency syndrome: a case report 167
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 167
A cyanobacterium-like body found in the stools of an HIV+ patient with diarrhoea 166
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort. 166
Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy 166
The elderly and direct antiviral agents: Constraint or challenge? 165
Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study. 162
Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study 162
Comment on: Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection 161
Chronic Inflammation in a Long-Term Cohort of HIV-Infected Patients According to the Normalization of the CD4:CD8 Ratio 160
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 160
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 159
Prevalence of urinary schistosomiasis in migrants in Apulia, a region of southern Italy, in the years 2006-2016 156
Knowledge, attitudes, and practices about HIV and other sexually transmitted infections among High School students in Southern Italy: A cross-sectional survey 155
Renal function changes in HCV-infected patients with chronic kidney disease during and after treatment with direct antiviral agents 154
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 154
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 154
Co-receptor switch during HAART is independent of virological success 153
Splenic abscesses as a first manifestation of Crohn's disease: A case report 153
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 153
Alterazioni oftalmoscopiche e fluorangiografiche in pazienti affetti da AIDS 151
Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection 150
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 150
Access to Health Services for Undocumented Immigrants in Apulia 149
Improved virological outcome in non-B patients: a possible role for baseline coreceptor tropism 149
Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America 149
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 147
Limiting severe outcomes and impact on intensive care units of moderate-intermediate 2009 pandemic influenza: role of infectious diseases units. 146
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA <50 cp/mL 145
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies 144
Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). 144
Gaining back what is lost: recovering the sense of smell in mild to moderate patients after COVID-19 141
A multidrug-resistant (MDR) HIV type 1 infection in a homosexual man and identified source patient 140
Evolution of antiretroviral prescription and response over a period of 8 years: An Italian multicentre observational prospective cohort study 140
Persistence of e antigen as prognostic marker in acute hepatitis B 139
CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR 139
Hepatic encephalopathy in the course of anti-HCV therapy with paritaprevir/ritonavir, ombitasvir, dasabuvir and ribavirin 139
V3 sequences and paired HIV isolates from 52 non-subtype B HIV type 1-infected patients 138
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study 138
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 138
Intrathecal immune response in human immunodeficiency virus infection 137
Are the proposed env mutations actually associated with resistance to maraviroc? 137
Epidemiological multicentric Italian society of infectious and tropical diseases study on prevalence of tropical diseases in hospitalized immigrants in Italy during 2002 136
Long-term efficacy and safety of switching from lamivudine + adefovir to tenofovir disoproxil fumarate in virologically suppressed patients 136
Mutational patterns of paired blood and rectal biopsies in HIV-infected patients on HAART 136
Effects of Therapy with Maraviroc on the Carotid Intima Media Thickness in HIV-1/HCV Co-infected Patients 136
L'anticorpo antinucleare (anti-HBc) e patologia acuta e cronica del fegato da virus B dell'epatite 135
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study. 135
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 135
Neutralizing antibodies to recombinant alpha-interferon and response to therapy in chronic hepatitis C virus infection 134
Premature lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors 134
Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens 134
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 133
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 133
Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections 132
Risk of AIDS in HIV seroconverters: a comparison between intravenous drug users and homosexual males 132
HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5years 132
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples 132
Frequent cervicovaginal shedding of HIV-1 in asymptomatic, non-severely immunodeficient women 131
Pulmonary Artery Filling Defects in Covid-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication? 131
Hepatitis B virus markers, alpha-fetoprotein and survival in fulminant viral hepatitis 130
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 130
HIV infection and protease genetic diversity in a rural area of the Southern Central African Republic 130
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 130
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 130
Immunological markers in HIV-infected pregnant and non-pregnant women 130
Tocilizumab and corticosteroids for COVID-19 treatment in elderly patients 129
Reduced concentrations of HIV-RNA and TNF-alpha coexist in CSF of AIDS patients with progressive multifocal leukoencephalopathy 129
Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases 129
HCV and diabetes: Towards a 'sustained' glycaemic improvement after treatment with DAAs? 128
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 128
Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study 127
Analisi della cinetica replicativa in cultura primaria di isolati di HIV-1 da soggetti in vario stadio di malattia 127
Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects 126
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 124
HIV-1 variability and progression to AIDS: a longitudinal study 124
Totale 16.145
Salva come PNG Salva come JPEG
Categoria #
all - tutte 197.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.420
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.304 0 0 36 232 137 182 103 195 182 170 449 618
2022/20234.421 796 315 183 447 629 516 38 502 771 34 98 92
2023/20241.492 143 341 83 72 94 392 39 38 28 41 30 191
2024/20256.241 89 114 685 215 110 538 333 553 278 322 932 2.072
2025/202614.018 1.843 725 1.094 1.548 1.303 743 1.533 397 1.235 1.203 447 1.947
2026/20272.095 494 798 803 0 0 0 0 0 0 0 0 0
Totale 48.454